Recent studies highlight the importance of vitamin K2 (VK2) in human health. However, there have been no clinical studies investigating the role of VK2 in the prevention or treatment of Alzheimer’s disease (AD), a debilitating disease for which currently there is no cure. A new research concluded that K2 has the potential to slow the progression of AD and contribute to its prevention.

Researchers from the Harvard Extension School and Pacific Northwest University considered the antiapoptotic and antioxidant effects of vitamin K2 and its impact on neuroinflammation, mitochondrial dysfunction, cognition, cardiovascular health, and gut dysbiosis. Scientist also examine the link between dysbiosis and VK2 in the context of the microbiome’s role in AD pathogenesis.

kobieta chora na alzheimera na ławce w parku
mężczyzna chory na alzheimera na spacerze

This review is the first to consider the physiological roles of VK2 in the context of AD, and, given the recent shift in AD research toward nonpharmacological interventions, our findings emphasize the timeliness and need for clinical studies involving VK2. The National Institutes of Health notes that correcting dietary deficiencies can help prevent or delay dementia caused by AD, and that what we eat affects our ability to think and remember.